Sangsangin Securities analyzed on the 16th that BioPlus is expected to grow significantly due to its improved distribution structure this year and the planned construction of a factory next year. No ...

New York, NY, Oct. 04, 2023 (GLOBE NEWSWIRE) -- BioPlus Acquisition Corp. (“BIOS” or the “Company”) (Nasdaq: BIOS) announced today that (i) BIOS, Avertix Medical, Inc. and certain other parties have ...

CarepathRx serves more than 20 health systems and 600 hospitals, with more than 2,000 employees nationwide Elevance Health is an Indianapolis-based health insurance provider Nautic Partners invests in ...

The acquisition is expected to close in the first half of 2023 Headquartered in Indianapolis, Elevance Health is a health insurance provider Nautic Partners targets the healthcare, industrials and ...

Explore the BioPlus Acquisition stock price history with detailed daily historical prices, including open, high, low, close, and volume data. Review past trends, identify key price levels, and find ...

BioPlus Specialty Pharmacy, one of the nation's leading innovative specialty pharmacies, names Nicholas Maroulis, Pharm.D. as Senior Vice President of Pharmacy Services and Angie Houck as Vice ...

ALTAMONTE SPRINGS, Fla. — BioPlus Specialty Pharmacy has appointed a new person to head its bleeding disorders program, the company said Tuesday. BioPlus announced the promotion of Shelley Moore to ...

BioPlus Specialty Pharmacy, one of the nation's leading innovative specialty pharmacies, names Mark Montgomery as President, as company continues ongoing growth. "Adding Mark as the new President of ...

BioPlus Specialty Pharmacy (BioPlus), one of the nation’s leading specialty pharmacies, today announced that Russell Gay has been named Chief Strategic Officer. In this position, Gay will provide key ...

ALEXANDRIA, Va. — BioPlus Specialty Pharmacy has joined the National Association of Specialty Pharmacy as a Silver Founding Member, the organization announced Wednesday. BioPlus is now one of over 70 ...

[Asia Economy Reporter Jang Hyowon] BioPlus (CEO Jeong Hyungyu) announced on the 13th that it has decided to invest 2.34 billion KRW in Procell Therapeutics (CEO Lee Byungkyu, hereinafter Procell), a ...